Company Mission

Subfertility annually impacts more than 75 million couples attempting pregnancy world wide, yet only 56% of these couples seek assistance concerning the problem and a mere 22% receive specific therapy. Clearly, subfertility is a rampant disease and current therapies are unacceptable or unaffordable for most couples. There is sizable market for the right product.

For ~37% of couples, the male’s semen is the sole or contributing cause of their subfertility problem. 

ParentPlus LLC was formed to alleviate male-factor subfertility by bringing innovative biotechnology to millions of subfertile couples for whom intra-uterine insemination (IUI) might be an appropriate therapy. This therapy, with spousal or donor sperm, is underutilized ― perhaps in part because it frequently is neglected in the popular press.

It is our belief that sperm from many subfertile men should be the target of a therapy based on modern biotechnology. Successful application of this concept could allow far more subfertile couples, when male-factor subfertility is a problem, to use IUI with spousal sperm to fulfill their dream of a having a baby. Hence, the focus of ParentPlus LLC is on innovative reproductive media to enhance success primarily via IUI, but also enhancing IVF. In due course, demonstrated increased “success rate” with IUI using ParentPlus products will increase acceptance of IUI as the low cost alternative to highly publicized expensive treatments.